149 related articles for article (PubMed ID: 15693110)
1. Common mechanisms in immune-mediated inflammatory disease.
Firestein GS; Corr M
J Rheumatol Suppl; 2005 Feb; 73():8-13; discussion 29-30. PubMed ID: 15693110
[TBL] [Abstract][Full Text] [Related]
2. The KRN mouse model of inflammatory arthritis.
Kyburz D; Corr M
Springer Semin Immunopathol; 2003 Aug; 25(1):79-90. PubMed ID: 12904893
[TBL] [Abstract][Full Text] [Related]
3. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase.
Bockermann R; Schubert D; Kamradt T; Holmdahl R
Arthritis Res Ther; 2005; 7(6):R1316-24. PubMed ID: 16277685
[TBL] [Abstract][Full Text] [Related]
4. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.
Nandakumar KS; Holmdahl R
Arthritis Res Ther; 2006; 8(6):223. PubMed ID: 17254316
[TBL] [Abstract][Full Text] [Related]
5. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.
Kamradt T; Schubert D
Arthritis Res Ther; 2005; 7(1):20-8. PubMed ID: 15642150
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease.
Schaller M; Burton DR; Ditzel HJ
Nat Immunol; 2001 Aug; 2(8):746-53. PubMed ID: 11477412
[TBL] [Abstract][Full Text] [Related]
7. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
[TBL] [Abstract][Full Text] [Related]
8. The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis.
Kyburz D; Carson DA; Corr M
Arthritis Rheum; 2000 Nov; 43(11):2571-7. PubMed ID: 11083282
[TBL] [Abstract][Full Text] [Related]
9. A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis.
Solomon S; Rajasekaran N; Jeisy-Walder E; Snapper SB; Illges H
Eur J Immunol; 2005 Oct; 35(10):3064-73. PubMed ID: 16180250
[TBL] [Abstract][Full Text] [Related]
10. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
11. Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow-derived cells of Ali18 mutant mice.
Abe K; Wechs S; Kalaydjiev S; Franz TJ; Busch DH; Fuchs H; Soewarto D; Behrendt H; Wagner S; Jakob T; Hrabé de Angelis M
Rheumatology (Oxford); 2008 Mar; 47(3):292-300. PubMed ID: 18276736
[TBL] [Abstract][Full Text] [Related]
12. Prevention of spontaneous arthritis by inhibiting homeostatic expansion of autoreactive CD4+ T cells in the K/BxN mouse model.
Jang E; Kim HR; Cho SH; Paik DJ; Kim JM; Lee SK; Youn J
Arthritis Rheum; 2006 Feb; 54(2):492-8. PubMed ID: 16447223
[TBL] [Abstract][Full Text] [Related]
13. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
[TBL] [Abstract][Full Text] [Related]
14. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
15. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).
Solomon S; Kolb C; Mohanty S; Jeisy-Walder E; Preyer R; Schöllhorn V; Illges H
Eur J Immunol; 2002 Mar; 32(3):644-51. PubMed ID: 11857338
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 can be a key positive regulator of inflammatory arthritis.
Ohmura K; Nguyen LT; Locksley RM; Mathis D; Benoist C
Arthritis Rheum; 2005 Jun; 52(6):1866-75. PubMed ID: 15934072
[TBL] [Abstract][Full Text] [Related]
18. Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI).
Schaller M; Stohl W; Benoit V; Tan SM; Johansen L; Ditzel HJ
Biochem Biophys Res Commun; 2006 Oct; 349(2):838-45. PubMed ID: 16949042
[TBL] [Abstract][Full Text] [Related]
19. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
